BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 34904791)

  • 1. Immune-relatedlncRNAs can predict the prognosis of acute myeloid leukemia.
    Li R; Wu S; Wu X; Zhao P; Li J; Xue K; Li J
    Cancer Med; 2022 Feb; 11(3):888-899. PubMed ID: 34904791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.
    Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D
    BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia.
    Zhu Y; He J; Li Z; Yang W
    BMC Bioinformatics; 2023 Feb; 24(1):37. PubMed ID: 36737692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the Integrated Prognostic Signature Associated with Immuno-relevant Genes and Long Non-coding RNAs in Acute Myeloid Leukemia.
    Zhao C; Wang Y; Sharma A; Wang Z; Zheng C; Wei Y; Wu Y; Liu P; Liu J; Zhan X; Schmidt-Wolf I; Tu F
    Cancer Invest; 2022 Sep; 40(8):663-674. PubMed ID: 35770858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the 7-lncRNA Signature as a Prognostic Biomarker for Acute Myeloid Leukemia.
    Liu CY; Guo HH; Li HX; Liang Y; Tang C; Chen NN
    Dis Markers; 2021; 2021():8223216. PubMed ID: 34966465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of m6A-Related lncRNAs Associated With Prognoses and Immune Responses in Acute Myeloid Leukemia.
    Li D; Liang J; Cheng C; Guo W; Li S; Song W; Song Z; Bai Y; Zhang Y; Wu X; Zhang W
    Front Cell Dev Biol; 2021; 9():770451. PubMed ID: 34869365
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemia.
    Li P; Li J; Wen F; Cao Y; Luo Z; Zuo J; Wu F; Li Z; Li W; Wang F
    Front Oncol; 2022; 12():966920. PubMed ID: 36276132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of tumor protein p53 mutation-based prognostic signatures for acute myeloid leukemia.
    Xie J; Chen K; Han H; Dong Q; Wang W
    Curr Res Transl Med; 2022 Sep; 70(4):103347. PubMed ID: 35483237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Analysis of Autophagy-Related Signature Uncovers Prognostic Predictor for Acute Myeloid Leukemia.
    Chen XX; Li ZP; Zhu JH; Xia HT; Zhou H
    DNA Cell Biol; 2020 Sep; 39(9):1595-1605. PubMed ID: 32783661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. m6A-related lncRNAs predict prognosis and indicate immune microenvironment in acute myeloid leukemia.
    Zhong F; Yao F; Cheng Y; Liu J; Zhang N; Li S; Li M; Huang B; Wang X
    Sci Rep; 2022 Feb; 12(1):1759. PubMed ID: 35110624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 10-Long Non-Coding RNA-Based Expression Signature as a Potential Biomarker for Prognosis of Acute Myeloid Leukemia.
    Tang P; Xie M; Wei Y; Xie X; Chen D; Jiang Z
    Med Sci Monit; 2019 Jul; 25():4999-5004. PubMed ID: 31278736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A three‑lncRNA signature for prognosis prediction of acute myeloid leukemia in patients.
    Wang F; Tian X; Zhou J; Wang G; Yu W; Li Z; Fan Z; Zhang W; Liang A
    Mol Med Rep; 2018 Aug; 18(2):1473-1484. PubMed ID: 29901168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a 4 lncRNAs-based prognostic risk scoring system in adults with acute myeloid leukemia.
    Zeng H; Wu H; Yan M; Tang L; Guo X; Zhao X
    Leuk Res; 2020 Jan; 88():106261. PubMed ID: 31739140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature.
    Fu D; Zhang B; Wu S; Zhang Y; Xie J; Ning W; Jiang H
    Front Immunol; 2021; 12():695865. PubMed ID: 34135913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of circRNA-lncRNA-miRNA-mRNA Competitive Endogenous RNA Network as Novel Prognostic Markers for Acute Myeloid Leukemia.
    Cheng Y; Su Y; Wang S; Liu Y; Jin L; Wan Q; Liu Y; Li C; Sang X; Yang L; Liu C; Wang Z
    Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32751923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia.
    Guo C; Gao YY; Ju QQ; Zhang CX; Gong M; Li ZL
    BMC Cancer; 2020 Sep; 20(1):841. PubMed ID: 32883226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of LOC541471, GDAP1, SOD1, and STK25 is associated with poor overall survival of patients with acute myeloid leukemia.
    Yu X; Chen C; Hu Y; Li K; Zhang Y; Chen Z; Nie D; Gao R; Huang Y; Zhong M; Wang C; Wang S; Zeng Y; Li Y; Zeng C
    Cancer Med; 2023 Apr; 12(7):9055-9067. PubMed ID: 36708053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Novel Prognostic Model for Acute Myeloid Leukemia Based on Immune-Related Genes.
    Li R; Ding Z; Jin P; Wu S; Jiang G; Xiang R; Wang W; Jin Z; Li X; Xue K; Wu X; Li J
    Front Immunol; 2021; 12():639634. PubMed ID: 34025649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.